About
Abionic SA is a Swiss medical technology company founded in 2010, originating from the École Polytechnique Fédérale de Lausanne (EPFL). Headquartered at the Biopôle innovation campus in Lausanne, Switzerland, with subsidiaries in the USA and Hong Kong, Abionic specializes in ultra-rapid in vitro diagnostic testing using proprietary nanofluidic technology. The company develops the abioSCOPE®, a point-of-care diagnostic platform that provides lab-quality results within minutes from a single drop of blood. This platform utilizes patented nanofluidic biosensors for rapid and accurate testing, enabling healthcare professionals to make timely diagnosis and treatment decisions for conditions such as sepsis, iron deficiency, respiratory allergies, and COVID-19. Abionic also offers disposable IVD CAPSULES for specific biomarkers, enhancing the diagnostic capabilities of the abioSCOPE®. Abionic serves hospitals, primary care providers, and healthcare professionals globally, aiming to improve clinical decision-making and personalize patient care. The company operates advanced laboratories and manufacturing facilities, fostering innovation and collaboration in medical technology.
Technologies
Keywords
Company Information
-
Employees 28
-
Founded 2010
-
Annual Revenue $5000000
-
Total Funding $25211468
Location
3 Route de la Corniche, Epalinges, Vaud, Switzerland, 1066